(Q48707820)

English

Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

atherosclerosis

1 reference

based on heuristic

inferred from title

hyperparathyroidism

1 reference

based on heuristic

inferred from title

Caroline Kistorp

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Henrik Vestergaard

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

author name string

Christina Gerlach Ogard

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Mads D Engelmann

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Steen Levin Nielsen

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

63

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

493-498

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Primary hyperparathyroidism and heart disease--a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Cardiac Abnormalities in Patients with Primary Hyperparathyroidism: Implications for Follow-Up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

B-type natriuretic peptide in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Cardiac hormones as diagnostic tools in heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

A new 99mTc-red blood cell labeling procedure for cardiac blood pool imaging: clinical results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Clinical applications of B-type natriuretic peptide (BNP) testing.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

C-reactive protein as a risk factor versus risk marker

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Characterization of tumor necrosis factor-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Interleukin-6 production and secretion by human parathyroids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Changes in proinflammatory cytokine activity after menopause

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Essential biochemistry and physiology of (NT-pro)BNP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Exercise capacity and mortality among men referred for exercise testing.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Death risk factor analysis in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02363.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2005.02363.X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/16268799

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48707820&oldid=1238040141"